Caricamento...
Risperidone versus placebo for schizophrenia
BACKGROUND: Risperidone is the first new‐generation antipsychotic drug made available in the market in its generic form. OBJECTIVES: To determine the clinical effects, safety and cost‐effectiveness of risperidone compared with placebo for treating schizophrenia. SEARCH METHODS: On 19th October 2015,...
Salvato in:
| Pubblicato in: | Cochrane Database Syst Rev |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
John Wiley & Sons, Ltd
2016
|
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6463908/ https://ncbi.nlm.nih.gov/pubmed/27977041 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD006918.pub3 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|